Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Generate Biomedicines, Inc. (the “Company”) for the period ended June 30, 2026 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 6, 2026 |
By: |
/s/ Michael Nally |
|
|
Michael Nally, M.B.A. |
|
|
Chief Executive Officer and Director (Principal Executive Officer) |
|
|
|
Date: August 6, 2026 |
By: |
/s/ Jason Silvers |
|
|
Jason Silvers, M.D., J.D. |
|
|
President and Chief Financial Officer (Principal Financial and Accounting Officer) |